TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ).
Dr. Reddy’s Laboratories Ltd. has released the transcript of its earnings call for the quarter ended June 30, 2025. The call, conducted on July 23, 2025, provides insights into the company’s financial performance and strategic direction. This release is part of their compliance with regulatory requirements and aims to keep stakeholders informed about the company’s operations and market positioning.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. operates in the pharmaceutical industry, providing a wide range of generic medications, active pharmaceutical ingredients, and proprietary products. The company focuses on delivering affordable and innovative medicines to patients worldwide, with a strong presence in both emerging and developed markets.
Average Trading Volume: 69,313
Technical Sentiment Signal: Strong Buy
Current Market Cap: 1073.2B INR
Learn more about DRREDDY stock on TipRanks’ Stock Analysis page.